These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8960265)
21. [Cefuroxime axetil (Zinnat)--laboratory and clinical study]. Vyhnánek F; Hejzlar M; Procházka M; Pellar T; St'astná L; Silarová J; Kittnar E; Vedral T Rozhl Chir; 1990 Oct; 69(10):668-73. PubMed ID: 2263996 [TBL] [Abstract][Full Text] [Related]
22. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli. Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655 [TBL] [Abstract][Full Text] [Related]
23. [New special agents registered in Austria. Zinnat (cefuroxime axetil, glaxo)]. Gartler W Wien Klin Wochenschr; 1991; 103(10):306-12. PubMed ID: 1858381 [No Abstract] [Full Text] [Related]
24. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability. Stoeckel K; Hofheinz W; Laneury JP; Duchene P; Shedlofsky S; Blouin RA Antimicrob Agents Chemother; 1998 Oct; 42(10):2602-6. PubMed ID: 9756762 [TBL] [Abstract][Full Text] [Related]
25. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study]. Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527 [TBL] [Abstract][Full Text] [Related]
26. Effect of dose and food on the bioavailability of cefuroxime axetil. Finn A; Straughn A; Meyer M; Chubb J Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins]. Kees F; Naber KG Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377 [TBL] [Abstract][Full Text] [Related]
31. Absorption of ester prodrugs in Caco-2 and rat intestine models. He X; Sugawara M; Takekuma Y; Miyazaki K Antimicrob Agents Chemother; 2004 Jul; 48(7):2604-9. PubMed ID: 15215116 [TBL] [Abstract][Full Text] [Related]
32. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers. Harding SM; Williams PE; Ayrton J Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686 [TBL] [Abstract][Full Text] [Related]
33. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates. Garcia-Rodriguez JA Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220 [No Abstract] [Full Text] [Related]
34. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)]. Thabaut A; Durosoir JL; Saliou P Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930 [TBL] [Abstract][Full Text] [Related]
37. Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests. Marchaim D; Sunkara B; Lephart PR; Gudur UM; Bhargava A; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Chopra T; Dhar S; Kaye KS Infect Control Hosp Epidemiol; 2012 Aug; 33(8):853-5. PubMed ID: 22759556 [No Abstract] [Full Text] [Related]
38. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment. Brink HS; Huisman RM; Geerlings W; de Jong PE Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822 [TBL] [Abstract][Full Text] [Related]